#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4421993	F	Cytotoxicity against human RPMI8226 cells assessed as reduction in cell viability incubated for 72 hrs by CT-Glo cytotoxicity assay	Homo sapiens	4	ALA4421723	cell-based format	Patent Bioactivity Data
2.	ALA4421994	F	Cytotoxicity against human NCI-H929 cells assessed as reduction in cell viability incubated for 72 hrs by CT-Glo cytotoxicity assay	Homo sapiens	4	ALA4421723	cell-based format	Patent Bioactivity Data
3.	ALA4421995	F	Cytotoxicity against human HL60 cells assessed as reduction in cell viability incubated for 72 hrs by CT-Glo cytotoxicity assay	Homo sapiens	4	ALA4421723	cell-based format	Patent Bioactivity Data
4.	ALA4421996	F	Cytotoxicity against human KG1a cells assessed as reduction in cell viability incubated for 72 hrs by CT-Glo cytotoxicity assay	Homo sapiens	4	ALA4421723	cell-based format	Patent Bioactivity Data
5.	ALA4421997	F	Cytotoxicity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by CT-Glo cytotoxicity assay	Homo sapiens	4	ALA4421723	cell-based format	Patent Bioactivity Data
6.	ALA4421998	F	Cytotoxicity against human SK-UT-1 cells assessed as reduction in cell viability incubated for 72 hrs by CT-Glo cytotoxicity assay	Homo sapiens	4	ALA4421723	cell-based format	Patent Bioactivity Data
7.	ALA4421999	F	Cytotoxicity against human Flow 2000 cells assessed as reduction in cell viability incubated for 72 hrs by CT-Glo cytotoxicity assay	Homo sapiens	4	ALA4421723	cell-based format	Patent Bioactivity Data
8.	ALA4422000	A	Cytotoxicity against human WI38 cells assessed as reduction in cell viability incubated for 72 hrs by CT-Glo cytotoxicity assay	Homo sapiens	4	ALA4421723	cell-based format	Patent Bioactivity Data
9.	ALA4422001	A	Cytotoxicity against human PBMC cells assessed as reduction in cell viability incubated for 72 hrs by CT-Glo cytotoxicity assay	Homo sapiens	4	ALA4421723	cell-based format	Patent Bioactivity Data
10.	ALA4422002	B	Binding affinity to nuclear export signal of topoisomerase 2alpha in human NCI-H929 cells assessed as potentiation of doxorubicin-induced apoptosis by measuring increase in cleaved caspase-3 levels at 25 uM pre-incubated for 20 hrs followed by addition of doxorubicin for 4 hrs	Homo sapiens	7	ALA4421723	cell-based format	Patent Bioactivity Data
11.	ALA4422003	B	Binding affinity to nuclear export signal of topoisomerase 2alpha in human RPMI8226 cells assessed as potentiation of doxorubicin-induced apoptosis by measuring increase in cleaved caspase-3 levels at 25 uM pre-incubated for 20 hrs followed by addition of doxorubicin for 4 hrs	Homo sapiens	7	ALA4421723	cell-based format	Patent Bioactivity Data
12.	ALA4422004	B	Binding affinity to nuclear export signal of topoisomerase 2alpha in human U266 cells assessed as potentiation of doxorubicin-induced apoptosis by measuring increase in cleaved caspase-3 levels at 25 uM pre-incubated for 20 hrs followed by addition of doxorubicin for 4 hrs	Homo sapiens	7	ALA4421723	cell-based format	Patent Bioactivity Data
13.	ALA4422005	F	Induction of apoptosis in human NCI-H929 cells assessed as increase in cleaved caspase-3 levels at 25 uM incubated for 20 hrs	Homo sapiens	7	ALA4421723	cell-based format	Patent Bioactivity Data
14.	ALA4422006	F	Induction of apoptosis in human RPMI8226 cells assessed as increase in cleaved caspase-3 levels at 25 uM incubated for 20 hrs	Homo sapiens	7	ALA4421723	cell-based format	Patent Bioactivity Data
15.	ALA4422007	F	Induction of apoptosis in human U266 cells assessed as increase in cleaved caspase-3 levels at 25 uM incubated for 20 hrs	Homo sapiens	7	ALA4421723	cell-based format	Patent Bioactivity Data
16.	ALA4422008	B	Inhibition of nuclear export of topoisomerase 2alpha in human NCI-H929 cells assessed as increase in nuclear top2alpha level at 25 uM by immunofluorescence microscopy relative to control	Homo sapiens	3	ALA4421723	cell-based format	Patent Bioactivity Data
17.	ALA4422009	B	Binding affinity to nuclear export signal of topoisomerase 2alpha in human NCI-H929 cells assessed as potentiation of doxorubicin-induced apoptosis by measuring increase in cleaved caspase-3 levels at 25 uM pre-incubated for 20 hrs followed by addition of doxorubicin for 4 hrs relative to control	Homo sapiens	4	ALA4421723	cell-based format	Patent Bioactivity Data
18.	ALA4422010	B	Inhibition of decatenation activity of human topoisomerase 2 using kinetoplast DNA up to 50 uM incubated for 30 mins by agarose gel electrophoresis	Homo sapiens	4	ALA4421723	protein format	Patent Bioactivity Data
19.	ALA4422011	A	Effect on Top2alpha protein levels in human RPMI8226 cells at 25 uM incubated for 20 hrs by Western blot analysis	Homo sapiens	4	ALA4421723	cell-based format	Patent Bioactivity Data
20.	ALA4422014	B	Inhibition of nuclear export signal of topoisomerase 2alpha in human NCI-H929 cells assessed as reduction in cytoplasmic localization of Top2alpha at 100 uM incubated for 24 hrs by Western blot analysis	Homo sapiens	5	ALA4421723	cell-based format	Patent Bioactivity Data